All product features corresponded with the valid specifications of the waldemar link (b)(4) at the time, when the item was produced.Neither the complaint samples, nor additional information has been submitted.Without this information an investigation regarding the root cause is not possible.According to the quality documentation review a product failure is not assumed.The report is delayed due to inconsistencies with regard to foreign event reporting to fda.After re-evaluation of the complaint we determined that it is reportable.We have addressed the inconsistency in reporting foreign events to fda through capa-(b)(4).
|